Fingerprint
Dive into the research topics of 'Metabonomics uncovers a reversible proatherogenic lipid profile during infliximab therapy of inflammatory bowel disease'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Metabonomics uncovers a reversible proatherogenic lipid profile during infliximab therapy of inflammatory bowel disease
Jacob Tveiten Bjerrum*, Casper Steenholdt, Mark Ainsworth, Ole Haagen Nielsen, Michelle A.C. Reed, Karen Atkins, Ulrich Leonhard Günther, Fuhua Hao, Yulan Wang
*Corresponding author for this work